2016
DOI: 10.1371/journal.pone.0163520
|View full text |Cite
|
Sign up to set email alerts
|

Critical Role of IRF-3 in the Direct Regulation of dsRNA-Induced Retinoic Acid-Inducible Gene-I (RIG-I) Expression

Abstract: The cytoplasmic viral sensor retinoic acid-inducible gene-I (RIG-I), which is also known as an IFN-stimulated gene (ISG), senses viral RNA to activate antiviral signaling. It is therefore thought that RIG-I is regulated in a STAT1-dependent manner. Although RIG-I-mediated antiviral signaling is indispensable for the induction of an appropriate adaptive immune response, the mechanism underlying the regulation of RIG-I expression remains elusive. Here, we examined the direct regulation of RIG-I expression by int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…MTb glycolipoproteins, lipoproteins, and glycolipids present in the lysate are ligands for TLR4 and TLR2, which can in turn trigger activation of IRF3 and, more broadly, type I IFNs (Falvo et al., 2011, Perkins and Vogel, 2015); thus, the TLR and IRF/IFN pathways may play a complementary role in this context. Indeed, we note that there is evidence that IRF3 can regulate the gene promoters of both RIG-I and MDA5 (Hayakari et al., 2016, Yount et al., 2007) and that interferon-stimulated gene factor 3 (ISGF-3) can regulate the PKR gene promoter (Ward and Samuel, 2003). Furthermore, given that NTZ can promote IRF3-driven IFN-β mRNA expression in addition to its ability to broadly amplify RLR activity (Jasenosky et al., 2019), it is intriguing to speculate that MTb and NTZ directly enhance gene expression of sensor molecules via their effects on upstream transcriptional activators.…”
Section: Discussionmentioning
confidence: 93%
“…MTb glycolipoproteins, lipoproteins, and glycolipids present in the lysate are ligands for TLR4 and TLR2, which can in turn trigger activation of IRF3 and, more broadly, type I IFNs (Falvo et al., 2011, Perkins and Vogel, 2015); thus, the TLR and IRF/IFN pathways may play a complementary role in this context. Indeed, we note that there is evidence that IRF3 can regulate the gene promoters of both RIG-I and MDA5 (Hayakari et al., 2016, Yount et al., 2007) and that interferon-stimulated gene factor 3 (ISGF-3) can regulate the PKR gene promoter (Ward and Samuel, 2003). Furthermore, given that NTZ can promote IRF3-driven IFN-β mRNA expression in addition to its ability to broadly amplify RLR activity (Jasenosky et al., 2019), it is intriguing to speculate that MTb and NTZ directly enhance gene expression of sensor molecules via their effects on upstream transcriptional activators.…”
Section: Discussionmentioning
confidence: 93%
“…TRAF3, along with NF-κB modulator protein NEMO [ 76 ], TRAF family member-associated NF-κB activator (TANK) [ 81 ] and NAK-associated protein 1 (NAP1) [ 82 ], regulates the activity of two noncanonical IKK-related kinases, TANK-binding kinase 1 (TBK1) and inducible IκB kinase (IKKi). The phosphorylation of interferon regulatory factors (IRFs), IRF3 and IRF7, by TBK1 and IKKi leads to the induction of type I IFN genes and a set of IFN-inducible genes that bind to IFN-stimulated response elements (ISREs) in the nucleus [ 83 ]. MAVS activates IRF3 through the ubiquitin-binding domains of NEMO, while NEMO itself activates TBK1 [ 84 ] through TRAF3 [ 85 ].…”
Section: Mitochondrial Antiviral Signaling (Mavs)mentioning
confidence: 99%
“…RIG-I is described to be overexpressed upon activation, 34 , 35 , 36 to confirm this molecular mechanism, its level of expression was measured by western-blot after 72 h of treatment with either 40 nM of mAb-siPLK1-5′ppp 1 or transfected with 40 nM of siPLK1-5′ppp ( Figure S10 ). In comparison with non-treated cells, a 31-fold increase of RIG-I expression was observed with both treatments ( Figure 4 C), thus confirming the previous RIG-I activation assays.…”
Section: Resultsmentioning
confidence: 97%